<DOC>
	<DOC>NCT02041273</DOC>
	<brief_summary>A relative bioavailability study of commercial palbociclib free base hard capsules to the isethionate salt palbociclib capsules ( used in Phase 1 and 2 studies) under different fasting conditions.</brief_summary>
	<brief_title>Relative Bioavailability Of Palbociclib (PD-0332991) Under Fed And Fasted Conditions</brief_title>
	<detailed_description />
	<mesh_term>Palbociclib</mesh_term>
	<criteria>Healthy male subjects and/or female subjects of nonchildbearing potential between the ages of 18 and 55 years. Evidence of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study. Evidence or history of clinically significant hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease. Any condition possibly affecting drug absorption.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>bioavailability</keyword>
	<keyword>bioequivalence</keyword>
	<keyword>AUC</keyword>
	<keyword>Cmax</keyword>
</DOC>